Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk patients — identifying gene-specific cancer associations they hope will inform future hereditary cancer test guidance.Read More
Ellen T. Matloff, President and CEO of My Gene Counsel, breaks down the controversy surrounding the recent 60 Minutes episode on Preimplantation Genetic Diagnosis (PGD). Listen to find out what PGD means, how it’s used and why its purpose is often misinterpreted.
One genetic testing company recently grabbed headlines by announcing that for just $249 they will be offering a cancer gene panel that will test for 19 hereditary cancer genes. There is no doubt that low-cost options like these will break access to genetic testing wide open.
Cancer Bytes: By Ellen Matloff
Welcome to Cancer Bytes, featuring interviews with people touched by cancer. We hope that by listening to stories from cancer survivors we can help you through your process of healing and coping with the disease.